Bladder cancer ranks 13th among cancer-related fatalities globally and is the 10th most frequent malignancy with a 75% of 5-year survival rate. Seventy percent of urinary bladder cancer cases are of noninvasive grade, and most instances are detected early. But in 70% of these patients, the ...
Urinary bladder cancer (UBC) has a high incidence rates in many southern and eastern European countries, in parts of Africa and the Middle East, and in North America. It exhibits a wide variety of histological types that goes from less aggressive to rapid-growing ones. In order to compare ...
Objectives: To examine contemporary rates of pathological features and mortality for adenocarcinoma of the urinary bladder in the USA using population-based data analysis. Methods: We relied on 10 024 patients with non-metastatic bladder cancer diagnosed between 2004 and 2013 within the Surveillance, ...
If BCa is diagnosed post-metastasis, the 5-year survival rate plummets to below 15%; conversely, early diagnosis when the cancer is confined to the bladder’s inner layer can push survival rates above 90% [2], which is crucial to improving patient outcomes. Presently, cystoscopy and urine ...
Radical surgery combined with chemotherapy and radiotherapy appeared to give the longest survival in the colonic tumours. Patients with prostatic cancer had a poorer survival rate than those with the same stage tumour but without bladder involvement, with renal failure secondary to obstructive uropathy ...
Current urine-based assays for bladder cancer (BCa) diagnosis lack accuracy, so the search for improved biomarkers continues. Through genomic and proteomic profiling of urine, we have identified a panel of biomarkers associated with the presence of BCa. In this study, we evaluated the utility of...
2.2.2 Bladder cancer Bladder cancer (BCa) is the most common malignant tumor of the urinary system. The change in indices associated with BCa is probably more quickly detected in the urine than in blood. Therefore, proteins in exosomes can be considered as biomarkers for BCa. Chen et al. ...
a tissue and urinary biomarker for bladder cancer Antara Datta1, Martin E Adelson1, Yakov Mogilevkin1,2, Eli Mordechai1, Abraham A Sidi2 and Jason P Trama1* Abstract Background: Bladder cancer is a significant healthcare problem in the United States of America with a high recurrence rate....
VI.B Invasive Bladder Cancer VI.B.1 Cystectomy Standard local treatment for nonmetastatic muscle invasive disease is radical cystectomy. Radical cystectomy offers excellent local control, thus optimizing survival for patients without metastatic disease at the time of surgery. Also, as compared with bla...
Proteome analysis of gelatin-binding proteins in urine from patients with bladder cancers Gelatin-bound proteins isolated from urine samples were separated by 2-D PAGE and subjected to Discussion Information on the level of cancer invasion is crucial to predict a survival rate and a recurrence probab...